Healthcare - Biotechnology - NASDAQ - US
$ 288.58
-4.66 %
$ 6.29 B
Market Cap
-11.53
P/E
Price Target
Average
31.38%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
46.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Madrigal Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for MDGL of $379 , with forecasts ranging from a low of $270 to a high of $425 .
MDGL Lowest Price Target
Wall Street Target
270 USD
-6.44%
MDGL Average Price Target
Wall Street Target
379 USD
31.38%
MDGL Highest Price Target
Wall Street Target
425 USD
47.27%
REVENUE FORECAST
Revenue Forecast Chart MDGL
EBIT FORECAST
EBIT Forecast Chart MDGL
NET INCOME FORECAST
Net Income Chart MDGL